These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome. Hanson JW; Myrianthopoulos NC; Harvey MA; Smith DW J Pediatr; 1976 Oct; 89(4):662-8. PubMed ID: 957016 [TBL] [Abstract][Full Text] [Related]
16. Thrombocytosis and hyposplenism in an infant with fetal hydantoin syndrome. Alvarez O; Miller JH; Coates TD Am J Pediatr Hematol Oncol; 1992; 14(1):62-5. PubMed ID: 1550265 [TBL] [Abstract][Full Text] [Related]
18. American Academy of Pediatrics Committee on Drugs: anticonvulsants and pregnancy. Pediatrics; 1979 Feb; 63(2):331-3. PubMed ID: 440824 [TBL] [Abstract][Full Text] [Related]
19. Harbeson v. Parke-Davis. Supreme Court of Washington, Jaunary 6, 1983 (98 Wash.2d 460, 656 P.2d 483). Malpractice. Med Law; 1985; 4(2):189-94. PubMed ID: 3999949 [No Abstract] [Full Text] [Related]
20. Cancer in the fetal hydantoin syndrome. Ehrenbard LT; Chaganti RS Lancet; 1981 Jul; 2(8237):97. PubMed ID: 6113474 [No Abstract] [Full Text] [Related] [Next] [New Search]